Low Back PainNCT03829631
Lumbar Brace Deployment in the Emergency Department for Benign Low Back Pain
A study testing Horizon 627 Lumbar Brace, Aspen Medical Company, Oak Canyon, Irvine, CA 92618 in people with Low Back Pain and Brace, run by University of Alberta at 1 site in Australia.
Trial summary
Low back pain accounts for billions of dollars in health care expenditures. Most cases of back pain do not have a clear cause. Thus, low back pain management methods usually rely on targeting people' pain and discomfort. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Low Back Pain, Brace, Emergencies
- What is being tested?
- Horizon 627 Lumbar Brace, Aspen Medical Company, Oak Canyon, Irvine, CA 92618
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 152 participants
- Where
- 1 siteAustralia
- Study dates
- 12 Jun 2019to 31 Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Aged between 18 and 65 years
- Ambulatory
- Able to read and understand English
- Living in Edmonton
- Presenting to an emergency department
Who cannot join
- Back pain due to systemic or specific disease such as known cancer, spinal infection, fracture, or ankylosing spondylitis
- Pregnancy
- Significant compression of the spinal cord/nerves
- Previous back surgery
- On-going workers' compensation or litigation cases
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Australia1 site, 1 recruiting
- Recruiting
Royal Perth Hospital
Perth
Dale Edgar
Dale.Edgar@health.wa.gov.au
About this study
Official title: Lumbar Brace Deployment in The Emergency Department for Benign Low Back Pain: Effectiveness and Impact on Pain, Spine Function, Analgesic Use and Community Resources
Low back pain accounts for billions of dollars in health care expenditures. Most cases of back pain do not have a clear cause. Thus, low back pain management methods usually rely on targeting people' pain and discomfort. Painkillers, including opioids, are usually prescribed in the emergency departments for people with low back pain. But, like all medications, painkillers can have side effects, and some of those can be serious. There are also serious concerns about the overuse of painkillers. Thus, newer pain management methods are needed to reduce the use of painkillers in people with low back pain. Lumbar braces are one of the underutilized low back pain management methods in the emergency departments. Like crutches for leg and ankle injuries, they can minimise movements of the spine. This may decrease people pain and improve their function. This may also reduce the use of painkillers. In support of this approach, two recent studies conducted in a primary-care setting observed a reduction in the use of painkillers in people with low back pain who wore lumbar braces. The investigators are conducting this study to determine if wearing a lumbar brace for 4 weeks following emergency department presentation will reduce people's pain and discomfort and increase spine function. This may decrease the use of painkiller and future use of healthcare resources. This research study may also assist emergency-department staff with offering new recommendations to improve the quality of clinical decisions.
Read the detailed description
BACKGROUND/SIGNIFICANCE
The global point prevalence of activity-limiting low back pain was 7.3% in 2015, implying that 540 million people were affected at one time. Although people with acute or chronic low back pain usually improve in the first six weeks, they usually suffer from low to moderate levels of pain and disability in the first year. Low back pain is an urgent global public health concern, accounting for billions of dollars in health care expenditures. Much of this spending is for high-cost, low-value care such as evaluating low back pain in the emergency department; only 3% of persons with low back pain attending the emergency department are admitted to the hospital while those who are discharged leave without effective pain control. This low-value approach is thought to increase use of additional health-related resources including repeat use of the emergency department for future low back pain complaints and use of opioids. This reduces limited available resources that should more appropriately be used for other health care needs.
While emergency departments routinely recommend analgesics for low back pain (paracetamol, nonsteroidal anti-inflammatory drugs, opioids, etc.), current guidelines do not support this approach; only nonsteroidal anti-inflammatory drugs are recommended as second-line/adjunctive treatment. As such, there is a critical need to provide emergency-department staff with better short-term pain control solutions. One underutilized pain-control solution in emergency departments is lumbar orthoses. Like crutches for leg or ankle injuries, lumbar orthoses can minimise lumbar spine movements, which can reduce pain and discomfort while preserving important aspects of daily function. In support of this approach, two recent randomised controlled trials conducted in a primary-care setting observed a reduced analgesic consumption in low back pain patients who received lumbar orthoses.
HYPOTHESES
- Wearing a semi-rigid lumbar brace for 4 weeks following emergency department presentation will reduce participant pain and discomfort;
- The same bracing protocol will improve spine function;
- The same bracing protocol will decrease analgesic consumption including opioids;
- The same bracing protocol will decrease future use of healthcare resources.
SPECIFIC AIMS
- PRIMARY: To determine if lumbar bracing for 30 days after the emergency department presentation will reduce low back pain;
- SECONDARY: To determine if this same bracing protocol will improve spinal function and quality of life;
- SECONDARY: To establish if this same bracing protocol will reduce prescription and/or consumption of analgesics;
- EXPLORATORY: To establish if this same bracing protocol will reduce back pain-related use of health resources (e.g., emergency department, primary care, imaging, and non-prescription management).
RESEARCH PLAN
Study Design
This project is a prospective, superiority, 1:1 allocation, randomised controlled trial with concealed allocation. Specifically, the investigators will recruit people with benign low back pain presenting to the Emergency Department. Superiority will be based on a minimally clinically significant difference of our primary outcome measure (Numerical Pain Rating Scale, a 0-10-point scale). Statisticians will be blinded to group allocation. The investigators will exclude those with a confirmed cause of low back pain (e.g. trauma), significant compression of the spinal cord/nerves and on-going workers' compensation or litigation cases.
Procedure
After obtaining approval from the University of Alberta's Health Research Ethics Board, the investigators will invite people with benign low back pain presenting to Emergency Department (to be determined) to consent and take part in the study. After enrolment, each participant will be given a study number to maintain and track her/his records. The participant will be then provided with a Research Electronic Data Capture (REDCap) secure web address to complete various data collection surveys (e.g. demographics).
Baseline session
The investigators will collect demographics, comorbidities, medication, and self-reported histories of imaging and treatment. Participants will use self-reported outcome tools to quantify pain (Numerical Pain Rating Scale) and function (Roland-Morris Disability Questionnaire). The investigators will then randomize participants to one of two arms: brace or no brace.
All participants will be instructed that the current study will not substitute their current back pain management program. Participants in the intervention arm will be fitted with a semi-rigid prefabricated lumbar brace (Horizon 627 Lumbar Brace, Aspen Medical Company, Oak Canyon, Irvine, CA 92618). The brace is a one-size adjustable design to fit waists ranging from 24-70 inches. Participants will be instructed to wear the brace for six weeks. As this brace is semi-rigid, it does not prevent motion - only reduces motion in the lumbar areas. Our prior work and that of others have shown that this type of bracing does not reduce spinal function and is not associated with atrophy.
Randomisation: the investigators will deploy the REDCap randomisation tool to assign participants evenly into the intervention and control groups. The tool uses a defined parameter (subject ID in this study) to create a template allocation table. The on-site research assistant will enter each participant's REDCap record and then click the "Randomize" button. This will trigger REDCap to check the allocation table and display the group to which the participant should be assigned. The assignment is permanent and not editable within the participant record and, like all other activity within REDCap, is tracked and not modifiable in the audit log.
Self-reported questionnaires: the investigators will measure participants' pain level using the Numeric Pain Rating Scale. the investigators will use the Roland-Morris Disability Questionnaire and the Oswestry Disability Index to measure participant function and disability level.
Immediately after wearing the brace (only the intervention group): To assess the immediate impact of the brace, participants will use self-reported outcome tools on the REDCap to quantify pain (Numeric Pain Rating Scale) immediately after wearing the brace.
To measure the quality (how tightly the brace has been worn) and quantity (how much time the brace has been worn) of brace usage, a low-powered portable heat and load monitoring system will be embedded within the pressure pad of the brace. The force measurement part of the monitoring system is sensitive to the forces normal to the brace surface, but not to shear forces, and can be deployed to monitor the quality of the brace wear by participants.28 The temperature part of the monitoring system gives an accurate and stable output over the temperature range from 5 °C to 50 °C,29 and can be deployed to monitor how long the brace has been worn during the brace treatment.
Follow-up (both groups)
All participants will receive a series of short message service (SMS) text messages 3 times/week for 4 weeks to evaluate Numerical Pain Rating Scale, Roland-Morris Disability Questionnaire, brace usage, and analgesic consumption. The investigators will also collect a series of outcomes and interview questions by SMS at 2 and 3 months.
The end of the enrollment
The investigators will use participant healthcare numbers (obtained at baseline with consent) to perform an exploratory analysis through the Alberta Bone and Joint Health Network of health care resource utilization in the year before and during the trial (e.g. prescriptions filled, primary care or emergency department visits, imaging usage, etc.).
ANALYSIS METHODS
Blinding
Due to the nature of each intervention, blinding will not be feasible for participants. However, the outcomes assessor, outcome adjudicators, and the statistician will be blinded to the actual allocation. The investigators will develop two interpretations of our results based on a blinded review of the primary outcome data (intervention A vs. intervention B). One scenario will assume intervention A was brace and the other will assume intervention A was routine recommendations. Only after our team has agreed that there will be no further changes in the interpretation of the scenarios will the randomisation code be broken, and the correct interpretation used in manuscript preparation.
Statistical Analysis
The investigators will employ a repeated model of analysis of variance to compare pain level between groups. The investigators will use age, gender, and pain severity as potential covariates if randomization does not result in group equivalence. The investigators will also estimate the effect size of differences between and within the groups for pain using Cohen's d.
- Conditions
- Low Back Pain, Brace, Emergencies, Pain, Health Care Resources
- Being tested
- Horizon 627 Lumbar Brace, Aspen Medical Company, Oak Canyon, Irvine, CA 92618
- Medical subject headings
- Low Back Pain, Emergencies, Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Horizon 627 Lumbar Brace, Aspen Medical Company, Oak Canyon, Irvine, CA 92618Device
The brace is an FDA Class I, one-size adjustable design to fit waists ranging from 24-70 inches. Participants will be instructed to wear the brace for six weeks during the daytime
| Study group | Role | What they receive |
|---|---|---|
| Intervention | Experimental | Participants will be instructed to follow their current low back pain management program, in addition, they will be instructed to wear a lumbar brace (Horizon 627 Lumbar Brace) during the day for four weeks only when they are in pain in addition to their current management program. Receives: Device: Horizon 627 Lumbar Brace, Aspen Medical Company, Oak Canyon, Irvine, CA 92618 |
| Control | No intervention | Participants will be instructed to follow their current low back pain management program. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in the pain level
The change in the pain level between the baseline and 6-week follow-up will be evaluated using the Numeric Pain Rating Scale [0-10]. The 11-point numeric scale ranges from '0' representing "no pain" to '10' representing the "worst pain imaginable".
Measured: Week 6
Change in the pain level
The change in the pain level between the baseline and 4-month follow-up will be evaluated using the Numeric Pain Rating Scale [0-10]. The 11-point numeric scale ranges from '0' representing "no pain" to '10' representing the "worst pain imaginable".
Measured: Month 4
Change in the pain level
The change in the pain level between the baseline and 8-month follow-up will be evaluated using the Numeric Pain Rating Scale [0-10]. The 11-point numeric scale ranges from '0' representing "no pain" to '10' representing the "worst pain imaginable".
Measured: Month 8
Change in the pain level
The change in the pain level between the baseline and 12-month follow-up will be evaluated using the Numeric Pain Rating Scale [0-10]. The 11-point numeric scale ranges from '0' representing "no pain" to '10' representing the "worst pain imaginable".
Measured: Month 12
Secondary outcomes (8)
Change in the self-reported disability level - Questionnaire A
The change in the self-reported disability between the baseline and 6-week follow-up will be evaluated using the Oswestry Disability Index [0-100 scale].
Measured: Week 6
Change in the self-reported disability level - Questionnaire A
The change in the self-reported disability between the baseline and 4-month follow-up will be evaluated using the Oswestry Disability Index [0-100 scale].
Measured: Month 4
Change in the self-reported disability level - Questionnaire A
The change in the self-reported disability between the baseline and 8-month follow-up will be evaluated using the Oswestry Disability Index [0-100 scale].
Measured: Month 8
Change in the self-reported disability level - Questionnaire A
The change in the self-reported disability between the baseline and 12-month follow-up will be evaluated using the Oswestry Disability Index [0-100 scale].
Measured: Month 12
Change in the self-reported disability level - Questionnaire B
The change in the self-reported disability between the baseline and 6-week follow-up will be evaluated using the Roland-Morris Low Back Pain and Disability Questionnaire Index [0-24 scale].
Measured: Week 6
Change in the self-reported disability level - Questionnaire B
The change in the self-reported disability between the baseline and 4-month follow-up will be evaluated using the Roland-Morris Low Back Pain and Disability Questionnaire Index [0-24 scale].
Measured: Month 4
Change in the self-reported disability level - Questionnaire B
The change in the self-reported disability between the baseline and 8-month follow-up will be evaluated using the Roland-Morris Low Back Pain and Disability Questionnaire Index [0-24 scale].
Measured: Month 8
Change in the self-reported disability level - Questionnaire B
The change in the self-reported disability between the baseline and 12-month follow-up will be evaluated using the Roland-Morris Low Back Pain and Disability Questionnaire Index [0-24 scale].
Measured: Month 12
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Feb 2019
- Study start12 Jun 2019
- Primary completion31 Dec 2026 (estimated)
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Low Back PainStudies of the same condition, open and under way.
- More trials run by University of AlbertaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- This is a prospective, superiority, 1:1 parallel randomised control trial with concealed allocation. Superiority will be based on a minimally clinically significant difference of our primary outcome measure (Numerical Pain Rating Scale, a 0-10 point scale).
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 152 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Alberta
- Sponsor type
- University, hospital or other
- Collaborators
- American Orthotic and Prosthetic Association, Curtin University
- Responsible party
- Sponsor
- Investigators
- Vahid Abdollah, PhD, Principal investigator, University of Alberta
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03829631
- Sponsor's protocol ID
- Pro00085904
- Status last verified
- Jan 2026
- First submitted
- 24 Jan 2019
- Last updated
- 2 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 2 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Lumbar Brace Deployment in The Emergency Department for Benign Low Back Pain: Effectiveness and Impact on Pain, Spine Function, Analgesic Use and Community Resources
- ClinicalTrials.gov ID
- NCT03829631
- Acronym / sponsor ID
- Pro00085904
- Conditions
- Low Back Pain, Brace, Emergencies, Pain, Health Care Resources
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 152 participants (estimated)
- Lead sponsor
- University of AlbertaUniversity, hospital or other
- Collaborators
- American Orthotic and Prosthetic Association, Curtin University
- Study start
- 12 Jun 2019 (actual)
- Primary completion
- 31 Dec 2026 (estimated)
- Study completion
- 31 Dec 2026 (estimated)
- First posted
- 4 Feb 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Low back pain accounts for billions of dollars in health care expenditures. Most cases of back pain do not have a clear cause. Thus, low back pain management methods usually rely on targeting people' pain and discomfort. Painkillers, including opioids, are usually prescribed in the emergency departments for people with low back pain. But, like all medications, painkillers can have side effects, and some of those can be serious. There are also serious concerns about the overuse of painkillers. Thus, newer pain management methods are needed to reduce the use of painkillers in people with low back pain. Lumbar braces are one of the underutilized low back pain management methods in the emergency departments. Like crutches for leg and ankle injuries, they can minimise movements of the spine. This may decrease people pain and improve their function. This may also reduce the use of painkillers. In support of this approach, two recent studies conducted in a primary-care setting observed a reduction in the use of painkillers in people with low back pain who wore lumbar braces. The investigators are conducting this study to determine if wearing a lumbar brace for 4 weeks following emergency department presentation will reduce people's pain and discomfort and increase spine function. This may decrease the use of painkiller and future use of healthcare resources. This research study may also assist emergency-department staff with offering new recommendations to improve the quality of clinical decisions.
Detailed description
BACKGROUND/SIGNIFICANCE
The global point prevalence of activity-limiting low back pain was 7.3% in 2015, implying that 540 million people were affected at one time. Although people with acute or chronic low back pain usually improve in the first six weeks, they usually suffer from low to moderate levels of pain and disability in the first year. Low back pain is an urgent global public health concern, accounting for billions of dollars in health care expenditures. Much of this spending is for high-cost, low-value care such as evaluating low back pain in the emergency department; only 3% of persons with low back pain attending the emergency department are admitted to the hospital while those who are discharged leave without effective pain control. This low-value approach is thought to increase use of additional health-related resources including repeat use of the emergency department for future low back pain complaints and use of opioids. This reduces limited available resources that should more appropriately be used for other health care needs.
While emergency departments routinely recommend analgesics for low back pain (paracetamol, nonsteroidal anti-inflammatory drugs, opioids, etc.), current guidelines do not support this approach; only nonsteroidal anti-inflammatory drugs are recommended as second-line/adjunctive treatment. As such, there is a critical need to provide emergency-department staff with better short-term pain control solutions. One underutilized pain-control solution in emergency departments is lumbar orthoses. Like crutches for leg or ankle injuries, lumbar orthoses can minimise lumbar spine movements, which can reduce pain and discomfort while preserving important aspects of daily function. In support of this approach, two recent randomised controlled trials conducted in a primary-care setting observed a reduced analgesic consumption in low back pain patients who received lumbar orthoses.
HYPOTHESES
- Wearing a semi-rigid lumbar brace for 4 weeks following emergency department presentation will reduce participant pain and discomfort;
- The same bracing protocol will improve spine function;
- The same bracing protocol will decrease analgesic consumption including opioids;
- The same bracing protocol will decrease future use of healthcare resources.
SPECIFIC AIMS
- PRIMARY: To determine if lumbar bracing for 30 days after the emergency department presentation will reduce low back pain;
- SECONDARY: To determine if this same bracing protocol will improve spinal function and quality of life;
- SECONDARY: To establish if this same bracing protocol will reduce prescription and/or consumption of analgesics;
- EXPLORATORY: To establish if this same bracing protocol will reduce back pain-related use of health resources (e.g., emergency department, primary care, imaging, and non-prescription management).
RESEARCH PLAN
Study Design
This project is a prospective, superiority, 1:1 allocation, randomised controlled trial with concealed allocation. Specifically, the investigators will recruit people with benign low back pain presenting to the Emergency Department. Superiority will be based on a minimally clinically significant difference of our primary outcome measure (Numerical Pain Rating Scale, a 0-10-point scale). Statisticians will be blinded to group allocation. The investigators will exclude those with a confirmed cause of low back pain (e.g. trauma), significant compression of the spinal cord/nerves and on-going workers' compensation or litigation cases.
Procedure
After obtaining approval from the University of Alberta's Health Research Ethics Board, the investigators will invite people with benign low back pain presenting to Emergency Department (to be determined) to consent and take part in the study. After enrolment, each participant will be given a study number to maintain and track her/his records. The participant will be then provided with a Research Electronic Data Capture (REDCap) secure web address to complete various data collection surveys (e.g. demographics).
Baseline session
The investigators will collect demographics, comorbidities, medication, and self-reported histories of imaging and treatment. Participants will use self-reported outcome tools to quantify pain (Numerical Pain Rating Scale) and function (Roland-Morris Disability Questionnaire). The investigators will then randomize participants to one of two arms: brace or no brace.
All participants will be instructed that the current study will not substitute their current back pain management program. Participants in the intervention arm will be fitted with a semi-rigid prefabricated lumbar brace (Horizon 627 Lumbar Brace, Aspen Medical Company, Oak Canyon, Irvine, CA 92618). The brace is a one-size adjustable design to fit waists ranging from 24-70 inches. Participants will be instructed to wear the brace for six weeks. As this brace is semi-rigid, it does not prevent motion - only reduces motion in the lumbar areas. Our prior work and that of others have shown that this type of bracing does not reduce spinal function and is not associated with atrophy.
Randomisation: the investigators will deploy the REDCap randomisation tool to assign participants evenly into the intervention and control groups. The tool uses a defined parameter (subject ID in this study) to create a template allocation table. The on-site research assistant will enter each participant's REDCap record and then click the "Randomize" button. This will trigger REDCap to check the allocation table and display the group to which the participant should be assigned. The assignment is permanent and not editable within the participant record and, like all other activity within REDCap, is tracked and not modifiable in the audit log.
Self-reported questionnaires: the investigators will measure participants' pain level using the Numeric Pain Rating Scale. the investigators will use the Roland-Morris Disability Questionnaire and the Oswestry Disability Index to measure participant function and disability level.
Immediately after wearing the brace (only the intervention group): To assess the immediate impact of the brace, participants will use self-reported outcome tools on the REDCap to quantify pain (Numeric Pain Rating Scale) immediately after wearing the brace.
To measure the quality (how tightly the brace has been worn) and quantity (how much time the brace has been worn) of brace usage, a low-powered portable heat and load monitoring system will be embedded within the pressure pad of the brace. The force measurement part of the monitoring system is sensitive to the forces normal to the brace surface, but not to shear forces, and can be deployed to monitor the quality of the brace wear by participants.28 The temperature part of the monitoring system gives an accurate and stable output over the temperature range from 5 °C to 50 °C,29 and can be deployed to monitor how long the brace has been worn during the brace treatment.
Follow-up (both groups)
All participants will receive a series of short message service (SMS) text messages 3 times/week for 4 weeks to evaluate Numerical Pain Rating Scale, Roland-Morris Disability Questionnaire, brace usage, and analgesic consumption. The investigators will also collect a series of outcomes and interview questions by SMS at 2 and 3 months.
The end of the enrollment
The investigators will use participant healthcare numbers (obtained at baseline with consent) to perform an exploratory analysis through the Alberta Bone and Joint Health Network of health care resource utilization in the year before and during the trial (e.g. prescriptions filled, primary care or emergency department visits, imaging usage, etc.).
ANALYSIS METHODS
Blinding
Due to the nature of each intervention, blinding will not be feasible for participants. However, the outcomes assessor, outcome adjudicators, and the statistician will be blinded to the actual allocation. The investigators will develop two interpretations of our results based on a blinded review of the primary outcome data (intervention A vs. intervention B). One scenario will assume intervention A was brace and the other will assume intervention A was routine recommendations. Only after our team has agreed that there will be no further changes in the interpretation of the scenarios will the randomisation code be broken, and the correct interpretation used in manuscript preparation.
Statistical Analysis
The investigators will employ a repeated model of analysis of variance to compare pain level between groups. The investigators will use age, gender, and pain severity as potential covariates if randomization does not result in group equivalence. The investigators will also estimate the effect size of differences between and within the groups for pain using Cohen's d.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- This is a prospective, superiority, 1:1 parallel randomised control trial with concealed allocation. Superiority will be based on a minimally clinically significant difference of our primary outcome measure (Numerical Pain Rating Scale, a 0-10 point scale).
| Arm | Type | Receives |
|---|---|---|
| Intervention | Experimental | Device: Horizon 627 Lumbar Brace, Aspen Medical Company, Oak Canyon, Irvine, CA 92618Participants will be instructed to follow their current low back pain management program, in addition, they will be instructed to wear a lumbar brace (Horizon 627 Lumbar Brace) during the day for four weeks only when they are in pain in addition to their current management program. |
| Control | No intervention | –Participants will be instructed to follow their current low back pain management program. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Aged between 18 and 65 years
- Ambulatory
- Able to read and understand English
- Living in Edmonton
- Presenting to an emergency department
Key exclusion criteria (5 listed)
- Back pain due to systemic or specific disease such as known cancer, spinal infection, fracture, or ankylosing spondylitis
- Pregnancy
- Significant compression of the spinal cord/nerves
- Previous back surgery
- On-going workers' compensation or litigation cases
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Horizon 627 Lumbar Brace, Aspen Medical Company, Oak Canyon, Irvine, CA 92618The brace is an FDA Class I, one-size adjustable design to fit waists ranging from 24-70 inches. Participants will be instructed to wear the brace for six weeks during the daytime | Device | Intervention |
Primary outcome
Change in the pain level
Time frame: Week 6
The change in the pain level between the baseline and 6-week follow-up will be evaluated using the Numeric Pain Rating Scale [0-10]. The 11-point numeric scale ranges from '0' representing "no pain" to '10' representing the "worst pain imaginable".
Change in the pain level
Time frame: Month 4
The change in the pain level between the baseline and 4-month follow-up will be evaluated using the Numeric Pain Rating Scale [0-10]. The 11-point numeric scale ranges from '0' representing "no pain" to '10' representing the "worst pain imaginable".
Change in the pain level
Time frame: Month 8
The change in the pain level between the baseline and 8-month follow-up will be evaluated using the Numeric Pain Rating Scale [0-10]. The 11-point numeric scale ranges from '0' representing "no pain" to '10' representing the "worst pain imaginable".
Change in the pain level
Time frame: Month 12
The change in the pain level between the baseline and 12-month follow-up will be evaluated using the Numeric Pain Rating Scale [0-10]. The 11-point numeric scale ranges from '0' representing "no pain" to '10' representing the "worst pain imaginable".
8 secondary outcomes
Change in the self-reported disability level - Questionnaire A
Time frame: Week 6
Change in the self-reported disability level - Questionnaire A
Time frame: Month 4
Change in the self-reported disability level - Questionnaire A
Time frame: Month 8
Change in the self-reported disability level - Questionnaire A
Time frame: Month 12
Change in the self-reported disability level - Questionnaire B
Time frame: Week 6
Change in the self-reported disability level - Questionnaire B
Time frame: Month 4
Change in the self-reported disability level - Questionnaire B
Time frame: Month 8
Change in the self-reported disability level - Questionnaire B
Time frame: Month 12
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Feb 2026.
- Individual participant dataSharing planned: No
Related trials for Low Back Pain
Not yet recruiting
Effects of Hip Hinge Exercises on Pain, Range of Motion and Functional Disability in Non-specific Low Back Pain.
Low Back Pain
Not yet recruiting
Effect of Lumbar Stabilization Exercises With and Without YTWL (Scapular Stabilization Exercises) on Reducing Chronic Low Back Pain and Related Disability. A Randomized Clinical Trial,
Chronic Non Specific Mechanical Low Back Pain
Not yet recruiting
Comparing Non-Medicine Strategies for Improving Low Back Pain
Chronic Low-back Pain (cLBP), High-Impact Chronic Pain (HICP)
Not yet recruiting
Effects of Whole-Body Vibration and Cervical Stabilization With Core Stabilization in Young Adults With Non-Specific Low Back Pain
Nonspecific Low Back Pain
Not yet recruiting
Spinery Basivertebral Nerve Ablation for Vertebrogenic Chronic Low Back Pain
Low Back Pain, Chronic Low Back Pain (CLBP)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Vahid Abdollah, PhD principal investigator
University of Alberta
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Horizon 627 Lumbar Brace, Aspen Medical Company, Oak Canyon, Irvine, CA 92618 in people with Low Back Pain and Brace, run by University of Alberta at 1 site in Australia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 2 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Australia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Vahid Abdollah, PhD (7804928889, v.abdollah@ualberta.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in the pain level (time frame: Week 6). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Feb 2026.